Brain cancer candidate touted for melanoma

Swiss drugmaker Novartis received an FDA nod for rare disease treatment Signifor LAR Tuesday, as orphan drug approvals reach new heights. The new approach shows "The Talk" has a sequel. Bayer consolidates OTC creative portfolio; Genentech R& …